TW205510B - - Google Patents

Download PDF

Info

Publication number
TW205510B
TW205510B TW080105474A TW80105474A TW205510B TW 205510 B TW205510 B TW 205510B TW 080105474 A TW080105474 A TW 080105474A TW 80105474 A TW80105474 A TW 80105474A TW 205510 B TW205510 B TW 205510B
Authority
TW
Taiwan
Prior art keywords
lipid
liposome
membrane
page
particle size
Prior art date
Application number
TW080105474A
Other languages
English (en)
Chinese (zh)
Original Assignee
Daiichi Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Co Ltd filed Critical Daiichi Co Ltd
Application granted granted Critical
Publication of TW205510B publication Critical patent/TW205510B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
TW080105474A 1990-07-16 1991-07-15 TW205510B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18737090 1990-07-16

Publications (1)

Publication Number Publication Date
TW205510B true TW205510B (enExample) 1993-05-11

Family

ID=16204819

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080105474A TW205510B (enExample) 1990-07-16 1991-07-15

Country Status (11)

Country Link
EP (1) EP0467275B1 (enExample)
JP (1) JP2609183B2 (enExample)
KR (1) KR100223129B1 (enExample)
AT (1) ATE144415T1 (enExample)
CA (1) CA2046997C (enExample)
DE (1) DE69122810T2 (enExample)
DK (1) DK0467275T3 (enExample)
ES (1) ES2097168T3 (enExample)
GR (1) GR3021982T3 (enExample)
HU (1) HU211991A9 (enExample)
TW (1) TW205510B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2041597B1 (es) * 1992-05-05 1994-06-01 Bazaco Joan Freixas Nuevo procedimiento para la preparacion de liposomas que encapsulan productos farmaceuticos y cosmeticos.
US5464696A (en) * 1992-08-13 1995-11-07 Bracco International B.V. Particles for NMR imaging
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
FI961893A0 (fi) * 1993-11-04 1996-05-03 Schering Ag Varautunut liposomivalmiste
DE19639811A1 (de) * 1996-09-27 1998-04-02 Artur Herzog Dr Mesmer Verwendung einer Liposomenlösung zur Verstärkung der Wirksamkeit und/oder Verminderung der Toxizität von Arzneimitteln
CA2376849C (en) * 1999-06-24 2008-10-14 Kyowa Hakko Kogyo Co., Ltd. Method of inhibiting leakage of drug encapsulated in liposomes
EP1585504A4 (en) * 2002-11-06 2009-07-15 Azaya Therapeutics Inc Protein stabilized liposomal formulations of pharmaceutical active ingredients
KR100965088B1 (ko) * 2004-12-07 2010-06-23 (주)아모레퍼시픽 유효성분의 안정화를 위한 다층 라멜라 베지클 및 그제조방법
GR20060100144A (el) * 2006-03-03 2007-10-17 Θεραπεια του καρκινου με χρηση οξαλιπλατινης εγκλεισμενης μεσα σε λιποσωματα και απο κοινου εγκλεισμος στο λιποσωμιακο μοριο περισσοτερων απο ενος φαρμακευτικου παρασκευασματος h gene
ES2325901B1 (es) * 2008-02-20 2010-07-06 Heber Farma Sl Vehiculizacion del factor de crecimiento epidermico a traves de biomembranas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419348A (en) * 1981-04-27 1983-12-06 Georgetown University Anthracycline glycoside compositions, their use and preparation
IE58981B1 (en) * 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
JPH0617309B2 (ja) * 1985-11-29 1994-03-09 株式会社ビタミン研究所 アドリアマイシン包埋リポソ−ム製剤
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
IL97538A (en) * 1986-12-23 1995-03-15 Liposome Co Inc Multilamellar liposomes containing nonphosphate guanindino aminoglycosides and their preparation.

Also Published As

Publication number Publication date
CA2046997A1 (en) 1992-01-17
EP0467275A1 (en) 1992-01-22
JP2609183B2 (ja) 1997-05-14
JPH05194191A (ja) 1993-08-03
EP0467275B1 (en) 1996-10-23
DK0467275T3 (enExample) 1997-02-17
DE69122810D1 (de) 1996-11-28
ES2097168T3 (es) 1997-04-01
HU211991A9 (en) 1996-01-29
DE69122810T2 (de) 1997-05-28
KR100223129B1 (ko) 1999-10-15
ATE144415T1 (de) 1996-11-15
KR920002165A (ko) 1992-02-28
CA2046997C (en) 2000-12-12
GR3021982T3 (en) 1997-03-31

Similar Documents

Publication Publication Date Title
Betageri et al. Liposome drug delivery systems
Alvi et al. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis
EP1838286B2 (de) Herstellung von lipidbasierten nanopartikeln unter einsatz einer dualen asymmetrischen zentrifuge
TW205510B (enExample)
Zhang et al. Quantifying binding of ethylene oxide–propylene oxide block copolymers with lipid bilayers
TW201106988A (en) Lipophilic drug delivery vehicle and methods of use thereof
CN1893926B (zh) 包含含有药物成分的亲脂胺的稳定脂质体组合物
JP2023145470A (ja) プラチナベースの両親媒性プロドラッグ
JP2022088508A (ja) 脂質粒子組成物および医薬組成物
JPS63246320A (ja) 非水溶性の有効成分のためのリン脂質輪送ビヒクル
JP2543114B2 (ja) リゾホスホリピドを用いる疎水性物質の可溶化
CA2529992C (en) Glycoside-containing liposome
WO2014034669A1 (ja) 非極性溶媒に分散性を有する細菌菌体成分を内封する脂質膜構造体およびその製造方法
EP4566594A1 (en) Lipid nanoparticles comprising long-chain ceramide and composition for cell death comprising same
WO1997048398A1 (en) Liposome preparations of indolocarbazole derivatives
RU2514000C1 (ru) Липосомальная композиция и способ ее получения
Guillod et al. Vesicles made of glycophospholipids with homogeneous (two fluorocarbon or two hydrocarbon) or heterogeneous (one fluorocarbon and one hydrocarbon) hydrophobic double chains
JP2021138626A (ja) 化学構造が剛直な化合物を含有するバイセル及びそれを含有する外用組成物
JPH0374323A (ja) リポソームの保存方法
JP2026072193A (ja) 脂質抽出物及びその製造方法、脂質組成物、並びに、脂質膜小胞及びその製造方法
Stadnichenko et al. Standardization of extrusion parameters during liposomal oxaliplatin creation
Kaur et al. Multifunctional liposome-based nanobiosystems
Karthick Development of formulation and evaluation of niosomal drug delivery system for improved anti-cancer activity
Awad Triggered release of liposome contents by the divalent anion B12H11SH (2-): Biochemical studies
CN103655213B (zh) 内含易热变性物质的脂质体和内含多个脂质体的保护胶囊